PFF Webinar Library

fda-stamp-of-approval-and-medications

The FDA's Drug Approval Process

Fri, Sep 28, 2018

Learn about FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Dr. Banu Karimi-Shah of the FDA - Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology Products joins us to give background information on the FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Recent Webinars

  • Jul
    23
    2025

    Managing Pulmonary Hypertension and Interstitial Lung Disease: Symptoms, Tests, and Treatment

    View Webinar
  • Jun
    25
    2025

    Understanding Mold-Related Hypersensitivity Pneumonitis: Diagnosis, Treatment, and Remediation

    View Webinar
  • Jun
    04
    2025

    PFF Clinical Trial Innovation (CTI) Webinar Series June 2025

    View Webinar
  • May
    28
    2025

    Debunking Myths and Advancing Care for ILD related to Autoimmune Diseases | Virtual

    View Webinar